‘Biolyst Scientific’ Announced as New Brand Name to Encompass EMS and Azer, Will Deepen Offerings to Clinical and Research Lab Customers

The integrated company delivers a broad portfolio of over 30,000 lab products across microscopy, histology, and other research areas – and is well-positioned to help clinicians and researchers advance discovery in the Life Sciences.

Hatfield, PA – July 22, 2024 – Life Science Newswire – Biolyst Scientific today announced its new brand name, reflecting the integration of Electron Microscopy Sciences (EMS) and Azer Scientific. The combined company blends extensive industry knowledge with an uncommon passion to make a difference – creating clinical, research, economic, and relationship value every day.

“This is an incredibly exciting day for Biolyst Scientific, our talented team, and our long-term customers and partners,” said Rajan Kapadia, President & CEO of Biolyst Scientific, who leads the combined entity. “New frontiers in Life Sciences are creating a need for accurate data acquisition and speed of discovery – we don't just deliver products on time, but elevate the customer experience by providing unparalleled reliability, precision, and a relentless focus on surfacing genuine solutions for the needs of the lab.”

The new name, ‘Biolyst,’ reflects the essential part the company plays in the Life Sciences discoveries that make life better for all. ‘Bio’ signals where impact is felt – in enhancing and extending life – and ‘lyst’ signifies its role as catalyst in helping clinical and research labs pursue breakthroughs with accuracy and efficiency. The EMS and Azer brand names will continue to exist as ‘power brands’ within the product portfolio.

While its broader solutions portfolio amplifies Biolyst Scientific’s impact, the company will maintain its uniquely collaborative relationship style and personalized focus to continue helping clinicians and researchers expand their discovery efforts cost-efficiently. This blend of scale and personal touch positions Biolyst as a significant partner to the most innovative clinical and research laboratories.     

Since the merger was announced in August 2023, the company prioritized commercial integration to ensure customers of today and tomorrow have a seamless sales and service experience that meets their needs, tracks their growth, and promotes new discoveries. Yet – to maximize customer experience continuity – the company plans to maintain EMS and Azer websites, ERP systems, and other key touchpoints.

Biolyst Scientific is backed by private investment firm Inverness Graham.

For more information, please visit www.biolyst.com.

ABOUT BIOLYST SCIENTIFIC
Formed through the merger of EMS and Azer – with a combined 70+ year track record – Biolyst Scientific is a leading provider of laboratory products across clinical and research settings. The company’s solution portfolio includes equipment, consumables, and other diagnostic tools to helps labs pursue breakthroughs with efficiency and accuracy. Biolyst has 200,000 sq ft of manufacturing and distribution footprint between its Hatfield, PA and Morgantown, PA campuses. 

ABOUT INVERNESS GRAHAM INVESTMENTS

Inverness Graham is a Philadelphia-based buyout firm that acquires innovative companies where technology is transforming traditional industry. The firm’s Flagship strategy focuses on high-growth businesses in Healthcare, Tech-Enabled Services/Software and Advanced Manufacturing. The firm’s Green Light strategy targets tech-enabled businesses where Environmental Sustainability is a key driver of accelerating growth. Inverness Graham executes a differentiated, repeatable model for value creation through its proprietary Strategic Platform Build approach. Founded by senior executives of the Graham Group, the firm builds upon a 60-year legacy of operational excellence, bringing substantial value creation resources and an innovative mindset to support its portfolio company partners.